MicroLumix to Show GermPass Technology at CES 2026

Jacksonville, FL – December 30, 2025 – On a mission to protect the vulnerable from the dangers of contaminated surfaces, MicroLumix today announced its participation at CES 2026 in Las Vegas.  The brand will demonstrate GermPass, the world’s only patented, automated disinfection technology (ADT) that harnesses UV-C light to eliminate 99.999% of germs on high volume touchpoints in just seconds and after every touch. 

Hospital acquired infections (HAIs) overwhelm already stressed healthcare systems and cause approximately 72,000 deaths each year in the U.S. More than 40% of HAIs trace directly to environmental touchpoints. HAIs create a vicious cycle, contributing to overload and burnout in frontline workers which, in turn, drives increases in infections. Now, the World Health Organization is sounding the alarm about surging antimicrobial resistance (AMR): one in six bacterial infections worldwide is now antibiotic resistant. Millions, including highly vulnerable patients in hospital settings, are threatened by microorganisms that are evolving faster than our defenses.

“At MicroLumix, we refuse to accept complacency in the face of a growing threat,” said Chris Hickey, CEO of MicroLumix.  “Our vision is hospitals and other public spaces transformed by cutting-edge automated disinfection technology – making us all safer and healthier, one reclaimed surface at a time.” 

Independent labs prove MicroLumix GermPass technology kills, on average, 99.999% of germs, including SARS-CoV-2, C. auris, Norovirus, MRSA, E. coli and more, via an innovative self-sealing UV-C light chamber that sanitizes high-volume touchpoints (HVTs) automatically after every touch – halting infection spread at the source. 100% chemical-free GermPass ADT provides eco-smart disinfection, eradicating surface germs without downtime, or added burden on care teams and reducing risk where other protocols fall short. 

“Vulnerable people deserve spaces that protect, not betray,” said Debra Vanderhoff, the founder of MicroLumix, who was inspired by the loss of a dear friend to a preventable HAI. “We aim to restore trust in every touch from a caregiver or loved one. Our automated GermPass solution provides superior protection to ineffective rituals, breaks a vicious cycle and rightfully restores healthcare workers’ focus on healing.”

Serving hospitals and beyond, MicroLumix offers GermPass automated disinfection technology solutions for high volume touchpoints (like elevators, doors and restrooms) in schools, cruise ships, convention centers, airports, manufacturing and distribution centers, hotels and more to prevent avoidable infections and create safer public spaces.

MicroLumix will demonstrate GermPass live at CES 2026 (January 6-9, Las Vegas), with hands-on experiences highlighting real-world need and applications for infection prevention. Visit Venetian Expo, Booth #53607 during CES show floor hours and/or Showstoppers on January 6 from 6 p.m. to 9 p.m. in the Grand Ballroom of the Bellagio Hotel for demonstrations and executive discussions.

Media are encouraged to schedule interviews or previews now.

About MicroLumix

MicroLumix protects the vulnerable from the dangers of contaminated surfaces—raising awareness of hidden pathogen threats on everyday touchpoints and creating GermPass innovative automated disinfection technology to eradicate them. MicroLumix empowers healthcare leaders, communities, and advocates to pioneer lasting protection, one safeguarded surface at a time. Learn more at www.microlumix.com.